Fesoterodine approved in the U.S.
UCB entitled to receive milestone payment and royalties from Pfizer
04-Nov-2008 -
UCB announced that the U.S. Food and Drug Administration (FDA) has approved the anti-muscarinic agent Toviaz® (fesoterodine fumarate) extended-release tablets for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency, and urinary frequency.
The NDA ...
dosing
food
milestone payments
+4